Faith Leaders Arrested on Capitol Hill During Protest Against Trump Immigration Policies and ICE Funding 
Putin Envoy Kirill Dmitriev to Visit Miami for Talks With Trump Administration Officials 
Trump Administration Gun Comments Spark Rift With NRA Ahead of Midterms 
Asian Currencies Trade Flat as Dollar Retreats After Fed Decision 
Oil Prices Surge Toward Biggest Monthly Gains in Years Amid Middle East Tensions 
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 
Trump Orders DHS to Avoid Protests in Democratic Cities Unless Federal Assets Are Threatened 
U.S. Eases Venezuela Oil Sanctions to Boost American Investment After Maduro Ouster 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis 
Asia Stocks Pause as Tech Earnings, Fed Signals, and Dollar Weakness Drive Markets 
U.S. and El Salvador Sign Landmark Critical Minerals Agreement to Boost Investment and Trade 
Trump to Announce New Federal Reserve Chair Pick as Powell Replacement Looms 
U.S. Government Faces Brief Shutdown as Congress Delays Funding Deal 
Copper Prices Hit Record Highs as Metals Rally Gains Momentum on Geopolitical Tensions 
Kevin Warsh’s Fed Nomination Raises Questions Over Corporate Ties and U.S.–South Korea Trade Tensions 
ICE Blocked From Entering Ecuador Consulate in Minneapolis During Immigration Operation 
U.S. President Donald Trump announced sweeping new trade tariffs Thursday evening, including a 100% levy on imported pharmaceutical products, marking one of his most aggressive moves to date in reshaping America’s trade policy. The new tariffs, set to take effect October 1, will also include a 25% duty on heavy truck imports, 50% on kitchen and bathroom fittings, and 30% on upholstered furniture.
According to Trump, the pharmaceutical tariffs will apply to all branded or patented products, though companies actively building manufacturing plants in the United States will be exempt. He specified that firms must have already broken ground or begun construction on U.S. facilities to qualify. Trump framed the move as a matter of national security and a necessary step to reduce dependency on foreign drug imports.
The United States imported over $212 billion worth of pharmaceutical products in 2024, government data shows. Trump has long criticized this reliance, arguing that it threatens U.S. security and weakens domestic industries. Earlier this year, he demanded that 17 major drugmakers lower domestic drug prices while raising them abroad to balance profits. In August, Trump warned he could hike tariffs as high as 250%, signaling the seriousness of his push for reshoring production.
The tariff threats have already spurred huge investment pledges from global pharma companies. Roche committed to investing $50 billion, while Novartis announced $23 billion in U.S. facilities. American firms including Johnson & Johnson (NYSE:JNJ) and Eli Lilly and Company (NYSE:LLY) are also ramping up domestic operations to hedge against the new trade policies.
These tariffs extend beyond pharmaceuticals, targeting industries like heavy trucks, fittings, and furniture—sectors Trump says need protection to revive U.S. manufacturing and safeguard jobs. While the full impact of these measures on trade partners remains unclear, they underscore the administration’s continued reliance on tariffs as a core tool in its economic agenda.
